Publicacións en colaboración con investigadores/as de Fundación Jiménez Díaz (17)

2022

  1. Efficacy, safety and cost-effectiveness of methotrexate, adalimumab or their combination in non-infectious non-anterior uveitis: a protocol for a multicentre, randomised, parallel three arms, active-controlled, phase III open label with blinded outcome assessment study

    BMJ open, Vol. 12, Núm. 3, pp. e051378

  2. Extracellular vesicles enriched in connexin 43 promote a senescent phenotype in bone and synovial cells contributing to osteoarthritis progression

    Cell death & disease, Vol. 13, Núm. 8, pp. 681

2021

  1. Incidence, diagnosis, and outcome of immune-mediated thrombotic thrombocytopenic purpura: A nationwide survey by the Spanish registry of thrombotic thrombocytopenic purpura

    Journal of Clinical Apheresis, Vol. 36, Núm. 4, pp. 563-573

2018

  1. European expert consensus statement on therapeutic goals in Fabry disease

    Molecular Genetics and Metabolism, Vol. 124, Núm. 3, pp. 189-203

  2. Targeting of chondrocyte plasticity via connexin43 modulation attenuates cellular senescence and fosters a pro-regenerative environment in osteoarthritis

    Cell Death and Disease, Vol. 9, Núm. 12

2017

  1. A multicentric study to evaluate the use of relative retention times in targeted proteomics

    Journal of Proteomics, Vol. 152, pp. 138-149

  2. Assessment of plasma chitotriosidase activity, CCL18/PARC concentration and NP-C suspicion index in the diagnosis of Niemann-Pick disease type C: A prospective observational study

    Journal of Translational Medicine, Vol. 15, Núm. 1

2015

  1. The Spanish biology/disease initiative within the human proteome project: Application to rheumatic diseases

    Journal of Proteomics, Vol. 127, pp. 406-413

2013

  1. Adipokines, molecular players at the crossroad between inflammation and oxidative stress: Role in arthropathies

    Studies on Arthritis and Joint Disorders (Springer New York), pp. 67-88

  2. Mutations in the gene encoding PDGF-B cause brain calcifications in humans and mice

    Nature Genetics, Vol. 45, Núm. 9, pp. 1077-1082

2012

  1. Adipokines as biomarkers of rheumatic diseases

    Drugs of the Future, Vol. 37, Núm. 8, pp. 591-597

  2. Adiponectin and Leptin Induce VCAM-1 Expression in Human and Murine Chondrocytes

    PLoS ONE, Vol. 7, Núm. 12

  3. Role of adipokines in atherosclerosis: Interferences with cardiovascular complications in rheumatic diseases

    Mediators of Inflammation, Vol. 2012

2011

  1. Adipokines: Biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity

    BioFactors, Vol. 37, Núm. 6, pp. 413-420

  2. Beyond fat mass: Exploring the role of adipokines in rheumatic diseases

    TheScientificWorldJournal, Vol. 11, pp. 1932-1947

1989

  1. Identification of the amino acid residues defining an intralocus determinant in the α1 domain of HLA-A molecules

    Immunogenetics, Vol. 30, Núm. 1, pp. 50-53

1986

  1. Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes

    Journal of Immunology, Vol. 137, Núm. 5, pp. 1642-1649